Skip to content

Clinical trials

Phase 2 Stroke trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20052
20081
20091
20102
20111
20121
20133
20141
20163
20192
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London3
GlaxoSmithKline2
NHS Greater Glasgow and Clyde2
University of Nottingham2
Adrian Parry-Jones1
AdvanceCor GmbH1
Anglia Ruskin University1
Astellas Pharma Inc1
Bayer1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke24
Ischemic Stroke5
Atrial Fibrillation2
Cerebral Hemorrhage2
Cerebrovascular Disorders2
Ischemic Attack, Transient2
Perceptual Disorders2
Amaurosis Fugax1
Aneurysm1
Antiphospholipid Syndrome1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.